Intersect ENT Stock Quote XENT - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

28.25

Bid

28.16

Ask

28.36

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

28.25

Open

Last Trade

Last Trade Time

Average Volume (3m)

Financial Volume

VWAP

FeaturedActelis Networks Bags Significant Orders for Seattle and Washington D.C. New Report Shows Their Potential as Smart City Market Eyes Trillions and Infrastructure Cyber Security Gains Importance - $ASNS

Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization

Data from first-of-its-kind study published in Current Medical Research and Opinion Patients receiving PROPEL® following endoscopic sinus surgery had statistically significant lower healthcare...

Intersect ENT Reports Third Quarter 2021 Financial Results

Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today reported financial results for the third quarter...

First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe

Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Helios Dr. Horst Schmidt Kliniken...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Intersect ENT, Inc.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Intersect ENT, Inc. PR Newswire NEW YORK, Aug. 9, 2021 NEW YORK, Aug. 9, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating...

Intersect ENT Shares Rise on Medtronic Takeover Deal

By Colin Kellaher Shares of Intersect ENT Inc. rose more than 12% on Friday after the drug-delivery company agreed to be acquired by medical-technology giant Medtronic PLC. Dublin-based Medtronic...

Medtronic to Buy Intersect ENT for $28.25/Share

By Colin Kellaher Medtronic PLC on Friday said it agreed to buy Intersect ENT Inc. in an all-cash deal with an implied enterprise value of about $1.1 billion. Dublin-based medical-technology...

Intersect ENT Reports Second Quarter 2021 Financial Results

Medtronic to Acquire Intersect ENT

Medtronic to Acquire Intersect ENT Acquisition to Add Innovative Bioabsorbable Drug Release Platform to Chronic Rhinosinusitis Portfolio Canada NewsWire DUBLIN and MENLO PARK, Calif., Aug. 6...

U.S Nationwide Commercial Availability of the VenSure™ Balloon Sinus Dilation System and Cube™ Navigation System Highlight Intersect ENT’s Continued Commitment to Providing Innovative, Solutions for Patients with Chronic Rhinosinusitis

VenSure and Cube Join the Company’s Portfolio of Localized Drug Delivery Creating an Integrated Offering of ENT Technologies to Treat CRS Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PALIPalisade Bio Inc	$ 2.90 (107.14%)	8.21M
AMPGAmplitech Group Inc	$ 2.66 (37.82%)	8.3M
DBVTDBV Technologies SA	$ 4.38 (33.13%)	2.41M
WHLRWheeler Real Estate Investment Trust Inc	$ 5.91 (32.51%)	983.99k
ECBKECB Bancorp Inc	$ 19.00 (25.99%)	104
PNBKPatriot National Bancorp Inc	$ 1.08 (-58.78%)	13
SPGCSacks Parente Golf Inc	$ 0.73 (-47.86%)	21.11k
AVGRAvinger Inc	$ 0.432 (-47.32%)	21.98k
HEPAHepion Pharmaceuticals Inc	$ 0.36 (-38.46%)	1
BCTXBriaCell Therapeutics Corporation	$ 0.72 (-34.55%)	147.72k
AMPGAmplitech Group Inc	$ 2.65 (37.31%)	8.31M
PALIPalisade Bio Inc	$ 2.89 (106.43%)	8.21M
RGTIRigetti Computing Inc	$ 6.85 (-7.18%)	2.76M
RZLVRezolve AI Ltd	$ 2.21 (11.06%)	2.62M
DBVTDBV Technologies SA	$ 4.39 (33.43%)	2.41M